Heart Disease Clinical Trials in San Antonio

Showing 61-80 of 293 trials

An Early Feasibility Study Evaluation of an Implant Free Interatrial Shunt to Improve Heart Failure

NCT06859970

The purpose of this early feasibility study is to evaluate the safety and feasibility of the device for percutaneous shunting of the interatrial septum and improvement of heart failure related symptoms. The primary goal is to determine if the device is safe to use. The findings from this study may be used to refine the intended patient population, the design of the device, or develop a subsequent randomized study.

Heart FailureHeart Failure NYHA Class IIIHeart Failure With Reduced Ejection Fraction+1 more

InterShunt Technologies, Inc.20 participantsStarted May 2025

Jonesboro, Arkansas, United States • Thousand Oaks, California, United States • Indianapolis, Indiana, United States +3 more locations

COMPLETEDPhase 3< 1 mile

Ferric Citrate for the Prevention of Renal Failure in Adults With Advanced Chronic Kidney Disease

NCT05085275

A 9-month randomized, double-blind, placebo-controlled study to compare the effect of fixed dose ferric citrate versus placebo in patients with advanced chronic kidney disease (eGFR ≤20 ml/min/1.73m2) on the composite endpoint of time to initiation of maintenance dialysis or all-cause mortality.

Anemia, Iron DeficiencyHyperphosphatemiaRenal Insufficiency, Chronic+4 more

USRC Kidney Research289 participantsStarted Mar 2022

Pine Bluff, Arkansas, United States • Chula Vista, California, United States • El Centro, California, United States +20 more locations

An Early Feasibility Study Evaluation of an Implant Free Interatrial Shunt to Improve Heart Failure

Ferric Citrate for the Prevention of Renal Failure in Adults With Advanced Chronic Kidney Disease

Heart Disease Trials in Other Cities

Hemodynamic-GUIDEd Management of Heart Failure

A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease

SURPASS Impella 5.5 Study

BATwire Implant Kit

Optisure Lead Post Approval Study

A Study to Evaluate Whether Macitentan is an Effective and Safe Treatment for Patients With Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular Disease

Cardiac Resynchronization Therapy in Previously Untreatable and High Risk Upgrade Patients

Study of JK07 in Patients With Chronic Heart Failure

A Study of Tirzepatide (LY3298176) in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) and Obesity: The SUMMIT Trial

Hybrid Coronary Revascularization Trial

Safety and Efficacy Study of reSept ASD Occluder for Treating Secundum ASD

Clinical Study Assessing the Efficacy and Safety of Macitentan in Fontan-palliated Subjects

Diagnosis and Treatment of CAD in Severe PAD After Lower Extremity Revascularization

Global Utilization And Registry Database for Improved heArt preservatioN

Abbott Vascular Medical Device Registry

A Study of AZD3427 in Participants With Heart Failure and Pulmonary Hypertension Group 2

Magna® Mitral Pericardial Bioprostheses Post-Approval Study Protocol

Effect of Evolocumab on Saphenous Vein Graft Patency Following Coronary Artery Bypass Surgery

Other Conditions in San Antonio